Jin Medical International Ltd.(ZJYL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ZJYL Jin Medical International Ltd.

Pre-Mkt 07-29 08:08:12 EDT

1.92

-0.08

-4.00%

High2.03	Low1.92	Vol9.40K
Open2.00	D1 Closing2.00	Amplitude5.50%
Mkt Cap15.03M	Tradable Cap3.73M	Total Shares7.83M
T/O18.56K	T/O Rate0.48%	Tradable Shares1.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ZJYL","market":"US","secType":"STK","nameCN":"Jin Medical International Ltd.","latestPrice":1.92,"timestamp":1785268800000,"preClose":2,"halted":0,"volume":9400,"delay":0,"changeRate":-0.040000000000000036,"floatShares":1941234,"shares":7827355,"eps":0.15218,"marketStatus":"Pre-Mkt","change":-0.08,"latestTime":"07-29 08:08:12 EDT","open":2.0004,"high":2.03,"low":1.92,"amount":18562,"amplitude":0.055,"askPrice":2.28,"askSize":100,"bidPrice":1.92,"bidSize":276,"shortable":3,"etf":0,"ttmEps":0.15218,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1785331800000},"marketStatusCode":1,"adr":0,"listingDate":1679976000000,"exchange":"NASDAQ","adjPreClose":1.92,"postHourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.92,"latestTime":"16:10 EDT","volume":4,"amount":7.68,"timestamp":1785269404749,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.27400774193658667},"requestUrl":"/m/hq/s/ZJYL","defaultTab":"news","newsList":[{"id":"2652242115","title":"Jin Medical International Files Form 3 for Director Ning Xue","url":"https://stock-news.laohu8.com/highlight/detail?id=2652242115","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652242115?lang=en_us&edition=fundamental","pubTime":"2026-07-17 03:13","pubTimestamp":1784229218,"startTime":"0","endTime":"0","summary":"Jin Medical International files Form 3 for director Ning XueJin Medical International filed an initial Form 3 showing Ning Xue as a director on July 16, 2026.Disclaimer:This news brief was created by ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL2MH5KQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651496317","title":"Jin Medical Names Ning Xue Independent Director, Replacing Jiayuan Tong","url":"https://stock-news.laohu8.com/highlight/detail?id=2651496317","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651496317?lang=en_us&edition=fundamental","pubTime":"2026-07-16 04:30","pubTimestamp":1784147458,"startTime":"0","endTime":"0","summary":"Jin Medical names Ning Xue independent director, replacing Jiayuan TongJin Medical International reported the resignation of independent director Jiayuan (James) Tong, effective July 9, 2026.Tong also","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL3xtq9M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZJYL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647302377","title":"Jin Medical International Announces Shareholder Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2647302377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647302377?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:31","pubTimestamp":1782765073,"startTime":"0","endTime":"0","summary":"Jin Medical International announces shareholder meetingsJin Medical International will hold a shareholder meeting in Changzhou City, China on July 9, 2026.Investors will vote on increasing Class B ord","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLbvjYD0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640152732","title":"Jin Medical dismisses auditor Audit Alliance, hires Enrome as new accounting firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2640152732","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640152732?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:03","pubTimestamp":1780574594,"startTime":"0","endTime":"0","summary":"Jin Medical replaced its independent auditor, dismissing Audit Alliance effective June 2, 2026.Enrome was appointed as the new independent registered public accounting firm for fiscal 2026.No audit disagreements were reported during Audit Alliance’s tenure, covering fiscal 2024 and fiscal 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL7hnRhv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633137823","title":"Jin Medical director Franklin Oliver St Clair Jr files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2633137823","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633137823?lang=en_us&edition=fundamental","pubTime":"2026-05-06 23:37","pubTimestamp":1778081842,"startTime":"0","endTime":"0","summary":"Jin Medical International filed an initial Form 3 naming Franklin Oliver St Clair Jr as a director, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 06, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL4pZZpZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630314176","title":"Jin Medical files Form 3 for director James Jiayuan Tong initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2630314176","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630314176?lang=en_us&edition=fundamental","pubTime":"2026-04-28 03:15","pubTimestamp":1777317342,"startTime":"0","endTime":"0","summary":"Jin Medical International filed an initial Form 3 for director James Jiayuan Tong, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL1tpDxF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZJYL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629511828","title":"Jin Medical’s Guo Yanru files initial beneficial ownership statement as director","url":"https://stock-news.laohu8.com/highlight/detail?id=2629511828","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629511828?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:45","pubTimestamp":1777041930,"startTime":"0","endTime":"0","summary":"Jin Medical International filed an initial Form 3 showing Guo Yanru as a director, with the report triggered March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL2lmTLJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620040338","title":"Jin Medical International approves 1-for-20 share consolidation effective March 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620040338","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620040338?lang=en_us&edition=fundamental","pubTime":"2026-03-18 04:31","pubTimestamp":1773779505,"startTime":"0","endTime":"0","summary":"Jin Medical said its board approved a 1-for-20 share consolidation of its authorized and issued ordinary shares. The consolidation is scheduled to take effect on March 16, 2026 at 09:00 a.m. ET, and the Class A shares will continue trading on Nasdaq under the symbol ZJYL. Jin Medical said the post-consolidation CUSIP for the Class A shares will be G5140V120. The company said the consolidation will reduce Class A shares outstanding to 6,827,355 from 136,547,100, and Class B shares to 1,000,000 from 20,000,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLbXkGpj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZJYL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619588734","title":"NASDAQ TRADE HALT CONTINUES  REASON NOT AVAILABLE AT 04:00 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2619588734","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619588734?lang=en_us&edition=fundamental","pubTime":"2026-03-16 16:00","pubTimestamp":1773648003,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT CONTINUES  REASON NOT AVAILABLE AT 04:00 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nAQN2LQD8Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZJYL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619149344","title":"Jin Medical International Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2619149344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619149344?lang=en_us&edition=fundamental","pubTime":"2026-03-14 07:55","pubTimestamp":1773446114,"startTime":"0","endTime":"0","summary":"19:50 EDT Jin Medical (ZJYL) International Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jin-medical-international-ltd-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jin-medical-international-ltd-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","ZJYL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618797421","title":"Jin Medical International approves 1-for-20 share consolidation effective March 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618797421","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618797421?lang=en_us&edition=fundamental","pubTime":"2026-03-12 07:30","pubTimestamp":1773271815,"startTime":"0","endTime":"0","summary":"Jin Medical said its board approved a 1-for-20 share consolidation of its authorized and issued ordinary shares. The consolidation is scheduled to take effect on March 16, 2026 at 09:00 a.m. ET. The Class A shares will continue trading on Nasdaq under the symbol ZJYL and will trade on a consolidation-adjusted basis from March 16. Jin Medical said the new CUSIP for the Class A shares after the consolidation will be G5140V120. The company said the consolidation will reduce Class A shares outstanding to 6.83 million and Class B shares outstanding to 1 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL9kdmXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618744679","title":"Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2618744679","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618744679?lang=en_us&edition=fundamental","pubTime":"2026-03-12 07:30","pubTimestamp":1773271800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nTUA55CTZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616378835","title":"Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2616378835","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616378835?lang=en_us&edition=fundamental","pubTime":"2026-03-04 01:15","pubTimestamp":1772558137,"startTime":"0","endTime":"0","summary":"• Boston Scientific faces recall of AXIOS Stent, triggering investigations.\n• $14.5 billion Penumbra acquisition adds debt and dilutes earnings.\n• Electrophysiology segment underperformed; sales guidance lowered.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/stocks/261640854-market-movers-bsx-20260303","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU0011850046.USD","BK4585","LU0823417653.USD","LU1791710582.SGD","LU0225283273.USD","ZJYL","LU0345769128.USD","BSX","LU2506952170.USD","LU1989764748.USD","BSX.AU","IE00BJJMRZ35.SGD","LU1989772923.USD","LU2506951958.HKD","LU0528227936.USD","BK4082","LU2362540622.SGD","LU2491050154.USD","LU2244417387.USD","SG9999001176.SGD","LU2362541513.USD","LU1291159041.SGD","LU0114720955.EUR","NMTC","LU0077335932.USD","BK7095","LU0266013472.USD","LU1791710400.SGD","LU1989771016.USD","LU0353189763.USD","LU0950375773.USD","LU0432979614.USD","BK4581","LU2242649171.HKD","SEM","IE00B4R5TH58.HKD","LU0345769631.USD","LU2087625088.SGD","LU2506952097.USD","BK4588","LU0122379950.USD","LU1153585028.USD","SG9999013999.USD","IE0002141913.USD","LU2357305700.SGD","LU0823417737.USD","LU1989764664.SGD","LU0353189680.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610364913","title":"JinMed FY 2025 net income attributable to shareholders drops 67.6% to USD 1.19 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610364913","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610364913?lang=en_us&edition=fundamental","pubTime":"2026-02-10 19:05","pubTimestamp":1770721522,"startTime":"0","endTime":"0","summary":"JinMed reported financial results for the fiscal year ended September 30, 2025. Net income attributable to shareholders was USD 1.19 million, reflecting a 67.6 percent decrease for the period. Net income reached USD 1.38 million for the year. The income tax provision stood at USD 0.76 million, representing an increase of 122.2 percent. JinMed primarily generates revenue from the design and manufacture of wheelchair products, wheelchair components, and other living aids, including oxygen concentrators, bath aids, and rehabilitative devices. The company’s products are distributed in Japan, China, and other international markets. For the period, the net income attributed to non-controlling interest was USD 0.19 million, a 2.74 times increase. JinMed highlighted continued focus on providing solutions for people with disabilities, the elderly, and those in recovery, through its portfolio of manual wheelchairs and related healthcare products.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL8qvkGt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610669431","title":"Jin Medical CEO Outlines Strategic Priorities and Growth Plans in Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2610669431","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610669431?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:41","pubTimestamp":1770673270,"startTime":"0","endTime":"0","summary":"Jin Medical International Ltd. , a leading provider of rehabilitation medical equipment, hosted a CEO Fireside Chat on February 2, 2026. During the session, CEO Dr. Erqi Wang discussed the company’s recent strategic priorities and long-term growth plans. Dr. Wang addressed topics such as the rationale behind the company’s recent reverse stock split proposal, emphasizing its role in both Nasdaq compliance and as a strategic reset to enhance capital structure and market perception. He also outlined Jin Medical’s commitment to clear market communication, disciplined capital allocation, and a long-term operational focus. Additionally, Dr. Wang highlighted the company's strategies for navigating industry evolution and managing geopolitical and supply chain risks, including supply chain diversification and regional manufacturing flexibility.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL79BY5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609305734","title":"Jin Medical CEO Outlines Strategic Priorities and Industry Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2609305734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609305734?lang=en_us&edition=fundamental","pubTime":"2026-02-05 21:57","pubTimestamp":1770299837,"startTime":"0","endTime":"0","summary":"Jin Medical International Ltd. , a leading provider of rehabilitation medical equipment, recently hosted a CEO Fireside Chat in which CEO Dr. Erqi Wang discussed the company's strategic priorities and outlook. Dr. Wang addressed topics such as the company's approach to reverse stock splits, emphasizing both compliance with Nasdaq listing standards and the opportunity for a strategic reset. He also outlined long-term value creation plans, highlighting disciplined capital allocation, enhanced market communication, and investment in manufacturing capabilities, product certification, and market expansion. Dr. Wang noted that the rehabilitation equipment industry is expected to see strong demand over the next three to five years due to aging populations and rising healthcare standards, while emphasizing the importance of managing geopolitical and supply chain risks, particularly in the context of US-China relations.Disclaimer: This news brief was created by Public Technologies  using genera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL2h7SdG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607902138","title":"Jin Medical International Delays Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2607902138","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607902138?lang=en_us&edition=fundamental","pubTime":"2026-01-31 05:00","pubTimestamp":1769806843,"startTime":"0","endTime":"0","summary":"Jin Medical International Ltd. has notified the SEC of a delay in filing its annual report on Form 20-F for the financial period ended September 30, 2025. The company cited that the report could not be filed on time without unreasonable effort or expense. No significant changes in results of operations are anticipated.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL3XqNNv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jin Medical International Delays Financial Report Filing","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ZJYL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606578245","title":"Jin Medical International Ltd. Hosts Management Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2606578245","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606578245?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:57","pubTimestamp":1769435831,"startTime":"0","endTime":"0","summary":"Jin Medical International Ltd. will host a management fireside chat on February 1, 2026, at 8:00 pm EST. The event will feature the Chief Executive Officer and the management team discussing the company's recent strategic priorities and long-term growth considerations. The fireside chat will be webcast on the company’s updated corporate website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via PR Newswire  on January 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL7S8Q7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZJYL","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zhjmedical.com","stockEarnings":[{"period":"1week","weight":-0.1233},{"period":"1month","weight":-0.1504},{"period":"3month","weight":-0.1312},{"period":"6month","weight":-0.3514},{"period":"1year","weight":-0.8549},{"period":"ytd","weight":-0.5636}],"compareEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":0.0163},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0675},{"period":"1year","weight":0.1632},{"period":"ytd","weight":0.0864}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":-0.059668},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.229323},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.20377},{"month":4,"riseRate":0.75,"avgChangeRate":0.071252},{"month":5,"riseRate":0.25,"avgChangeRate":-0.161015},{"month":6,"riseRate":0.25,"avgChangeRate":0.15527},{"month":7,"riseRate":0.75,"avgChangeRate":0.091909},{"month":8,"riseRate":0.666667,"avgChangeRate":0.03461},{"month":9,"riseRate":0.333333,"avgChangeRate":0.156915},{"month":10,"riseRate":0,"avgChangeRate":-0.491729},{"month":11,"riseRate":0.666667,"avgChangeRate":0.427394},{"month":12,"riseRate":0.333333,"avgChangeRate":3.012483}],"exchange":"NASDAQ","name":"Jin Medical International Ltd.","nameEN":"Jin Medical International Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jin Medical International Ltd.(ZJYL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jin Medical International Ltd.(ZJYL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jin Medical International Ltd.,ZJYL,Jin Medical International Ltd.股票,Jin Medical International Ltd.股票老虎,Jin Medical International Ltd.股票老虎国际,Jin Medical International Ltd.行情,Jin Medical International Ltd.股票行情,Jin Medical International Ltd.股价,Jin Medical International Ltd.股市,Jin Medical International Ltd.股票价格,Jin Medical International Ltd.股票交易,Jin Medical International Ltd.股票购买,Jin Medical International Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jin Medical International Ltd.(ZJYL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jin Medical International Ltd.(ZJYL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction